Statistical optimization of oral vancomycin-eudragit RS nanoparticles using response surface methodology

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 4, 2012, Pages 1001-1012

  Loveymi, Badir Delf ^a,b   Jelvehgari, Mitra ^a,c   Zakeri Milani, Parvin ^a,d   Valizadeh, Hadi ^a,e  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Eudragit RS100; Nanoparticles; Optimization; Response surface methodology; Vncomycin

Indexed keywords

EUDRAGIT RS; NANOPARTICLE; VANCOMYCIN;

ARTICLE; DRUG DIFFUSION; DRUG EFFICACY; DRUG SYNTHESIS; EVAPORATION; IN VITRO STUDY; NANOENCAPSULATION; PHYSICAL CHEMISTRY; REACTION OPTIMIZATION; REGRESSION ANALYSIS; RESPONSE SURFACE METHOD; SPECTROPHOTOMETRY; ZETA POTENTIAL;

EID: 84871350237     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hachicha W, Kodjikian L and Fessi H. Preparation of vancomycin microparticles: Importance of preparation parameters. Int. J. pharm. (2006) 324: 176-184.
2. okochi H and M Nakano. Preparation and evaluation of w/o/w type emulsions containing vancomycin. Advan. Drug Deliver. Review (2000) 45: 5-26.
3. Gavini E, Chetoni P, Cossu M and Alvarez MG. PLGA microspheres for the ocular delivery of a peptide drug, van comycin using emulsifcation/spray-drying as the preparation method: in-vitro/in-vivo studies. Eur. J. Pharm. Biopharm.(2004) 57: 207-212.
4. Mahboubian A, Hashemein SK, Moghadam SH, Atyabi F and Dinarvand R. Preparation and in-vitro evaluation of controlled release plga microparticles containing triptoreline. Iranian J. Pharm. Res. (2010) 9: 369-378
5. Page-Clisson ME and Pinto-Alphandary H. Development of ciprofoxacin-loaded nanoparticles: physicochemical study of the drug carrier. J. Control. Rel. (1998) 56: 23-32.
6. Grislain L, Couvreur P and Lenaerts V. Pharmacokinetics and distribution of a biodegradable drug-carrier. Inter. J. Pharm. (1983) 15: 335-345.
7. Jelvehgari M, Barar J, Valizadeh H, Shadro S and Nokhodchi A. Formulation, characterization and in- vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique. Pharm. Dev. Tech. (2011) 1-8.
8. Delie F and Blanco-Preto MJ. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecul. (2005) 10: 65-80.
9. Lewis GA, Mathieu D and Phan RTL. Pharmaceutical experimental design. Informa Healthcare (1998) 185-246.
10. Dey S, Pramanik S and Malgope A. Formulation and optimization of sustained release stavudine microspheres using response surface methodology. ISRN Pharmaceutics (2011).
11. Sheikh H. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int. J. pharm. (2007) 344: 53-61.
12. Jelvehgari M, Barar J, Valizadeh H and Heidari N. Preparation and Evaluation of Poly (-caprolactone) Nanoparticles-in-Microparticles by W/O/W Emulsion Method. Iran. J. Bas. Med. Sci. (2010) 13: 1-8.
13. Moore JW and Flanner HH. Mathematical comparison of dissolution profiles. Pharm. Tech. (1996) 20: 64-74.
14. Khan KA. The concept of dissolution effciency. J. Pharm. Pharmacol.(1975) 27: 48.
15. Dashevsky A and Zessin G. The effect of ethylcellulose molecular weight on the properties of theophylline microspheres. J. Microencapsul. (1997) 14: 273-280.
16. Das SK. In-vitro dissolution profile of theophylline loaded ethyl cellulose microspheres prepared by emulsifcation solvent evaporation. Drug Dev. Ind. Pharm. (1991) 17: 2521-2528.
17. Narendra C, Srinath M and Prakash Rao B. Development of three layered buccal compact containing metoprolol tartrate by statistical optimization technique. Int. J. Pharm.(2005) 304:102-114.
18. Hoffart V, Ubrich H, Simonin C. Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics. Drug Dev. Ind. Pharm. (2002) 28: 1091-1099.
19. Youan BBC, Jackson TL and Dickens L. Protein release profiles and morphology of biodegradable microcapsules containing an oily core. J. Control. Rel. (2001) 76: 313-326.
20. Danzer LA. Liquid-chromatographic determination of cephalosporins and chloramphenicol in serum. Clinic. Chem. (1983) 29: 856.
21. Amsden B. The production of uniformly sized polymer microspheres. Pharm. Res. (1999) 16:1140-1143.
22. Alex R and Bodmeier R. Encapsulation of water- soluble drugs by a modifed solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. In J. Microencapsul. (1990) 347-355.
23. Ogawa Y, Yamamoto M, Okada H, Yashiki T and Shimamoto T. A new technique to effciently entrap leuprolide acetate into microcapsules of polylactic acid or copoly (lactic/glycolic) acid. Chem. Pharm. Bul. (1988) 36: 1095-1103.
24. Pignatello R, Vandelli MA and Giunchedi P. Properties of tolmetin-loaded Eudragit RL100 and Eudragit RS 100 microparticles prepared by different techniques. STP Pharm. Sci. (1997) 7: 148-157.
25. Sahoo SK, Mallick AA and Barik BB. Formulation and in-vitro Evaluation of Eudragit® Microspheres of Stavudine. Trop. J. Pharm. Res. (2007) 4: 369.
26. Tsai YL, C.-C. Jong, Chen H. Preparation of double- encapsulated microcapsules for mitigating drug loss and extending release. J. Microencapsul. (2001) 18: 701-711.
27. Martin A, Bustamante P and Chun AHC. Physical pharmacy: physical chemical principles in the pharmaceutical sciences. Lea & Febiger: Philadelphia (1993) 135-137.
28. Gupta MM and Saini TR. Preformulation parameters characterization to design, development and formulation of vancomycin hydrochloride tablets for psudomembranous colitis. Int. J. Pharm. Res. Dev. (2009) 1.
29. Chiao CSL and Price JC. Formulation, preparation and dissolution characteristics of propranolol hydrochloride microspheres. J. Microencapsul. (1994) 11:153-159.
30. Barzegar-Jalali M. Kinetic analysis of drug release from nanoparticles. J. Pharm. Pharm. Sci. (2008) 11: 167-77.